Literature DB >> 20825565

14. Coccygodynia.

Jacob Patijn1, Markus Janssen, Salim Hayek, Nagy Mekhail, Jan Van Zundert, Maarten van Kleef.   

Abstract

Coccygodynia is painful condition localized in the region of the coccyx. In most cases a traumatic etiology is present. In the idiopathic form other causes such as infections and tumor have to be excluded. Coccygodynia can also be the result of pain referred from visceral structures due to conditions such as disorders of the rectum, the colon sigmoideum, and the urogenital system. In case of a traumatic etiology the diagnosis is made based on the typical medical history whereby the pain is provoked by prolonged sitting and cycling. Lateral images of the coccyx are always indicated. The same is true for manual examination of the coccyx. In case of absence of provocation of the coccygeal pain by prolonged sitting and manual examination neurological causes such as lumbar disc hernias are a possible reason for the coccygodynia. In the acute phase the first choice of treatment are NSAIDs. Treatment for patients with severe pain in the chronic phase consists of manual therapy and/or a local injection of local anesthetic and corticosteroid into the painful segment (2 C+). Other interventional treatments such as intradiscal injections, ganglion impar block, radiofrequency treatment and caudal block are advised only under study conditions (0). Coccygectomy is not recommended because of long-term moderate results and the chance of major complications.
© 2010 The Authors. Pain Practice © 2010 World Institute of Pain.

Entities:  

Mesh:

Year:  2010        PMID: 20825565     DOI: 10.1111/j.1533-2500.2010.00404.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  13 in total

1.  The efficacy of the ganglion impar block in perineal and pelvic cancer pain.

Authors:  Joana Sousa Correia; Manuel Silva; Clara Castro; Lina Miranda; Ana Agrelo
Journal:  Support Care Cancer       Date:  2019-03-18       Impact factor: 3.603

Review 2.  Ganglion impar blockade: a review.

Authors:  Julian Trevor Scott-Warren; Victoria Hill; Anand Rajasekaran
Journal:  Curr Pain Headache Rep       Date:  2013-01

3.  Favourable outcomes of coccygectomy for refractory coccygodynia.

Authors:  B Haddad; V Prasad; W Khan; M Alam; S Tucker
Journal:  Ann R Coll Surg Engl       Date:  2014-03       Impact factor: 1.891

4.  The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia.

Authors:  Canan Gönen Aydın; Aydan Örsçelik; Mustafa Cantay Gök; Yunus Emre Akman
Journal:  Med Princ Pract       Date:  2020-01-10       Impact factor: 1.927

5.  A comparison of conservative interventions and their effectiveness for coccydynia: a systematic review.

Authors:  Paul D Howard; Andrea N Dolan; Anthony N Falco; Brett M Holland; Caitlin F Wilkinson; Anna M Zink
Journal:  J Man Manip Ther       Date:  2013-11

6.  Effects of Extracorporeal Shock Wave Therapy on Pain in Patients With Chronic Refractory Coccydynia: A Quasi-Experimental Study.

Authors:  Shila Haghighat; Mahboobeh Mashayekhi Asl
Journal:  Anesth Pain Med       Date:  2016-06-01

7.  Analysis of Sacrococcygeal Morphology in Koreans Using Computed Tomography.

Authors:  Min Geun Yoon; Myung-Sang Moon; Bong Keun Park; Hohyoung Lee; Dong-Hyeon Kim
Journal:  Clin Orthop Surg       Date:  2016-11-04

8.  Management of coccydynia in the absence of X-ray evidence: Case report.

Authors:  Samantha Dayawansa; David Garrett; Marcus Wong; Jason H Huang
Journal:  Int J Surg Case Rep       Date:  2018-11-24

Review 9.  "Evidence-Based Interventional Pain Medicine According to Clinical Diagnoses": Update 2018.

Authors:  Frank Huygen; Jan Willem Kallewaard; Maurits van Tulder; Koen Van Boxem; Kris Vissers; Maarten van Kleef; Jan Van Zundert
Journal:  Pain Pract       Date:  2019-05-02       Impact factor: 3.183

10.  Retrospective evaluation of pain in patients with coccydynia who underwent impar ganglion block.

Authors:  Ozlem Sagir; Hafize Fisun Demir; Fatih Ugun; Bulent Atik
Journal:  BMC Anesthesiol       Date:  2020-05-11       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.